152 related articles for article (PubMed ID: 10833913)
1. [Thrombosis prophylaxis in orthopedic surgery].
Finsen V
Tidsskr Nor Laegeforen; 2000 Feb; 120(5):565-7. PubMed ID: 10833913
[TBL] [Abstract][Full Text] [Related]
2. Duration of thrombosis prophylaxis in orthopaedic surgery.
Finsen V
Ann Chir Gynaecol; 2001; 90(2):105-8. PubMed ID: 11459258
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolism after elective and post-traumatic hip surgery--a controlled prophylactic trial with dextran 70 and low-dose heparin.
Bergqvist D; Efsing HO; Hallböök T; Hedlund T
Acta Chir Scand; 1979; 145(4):213-8. PubMed ID: 386676
[TBL] [Abstract][Full Text] [Related]
4. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
5. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
6. Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients.
Kolb G; Bodamer I; Galster H; Seidlmayer C; Grambach K; Koudela K; Eisele RR; Becker C; Paal V; Spannagel U; Brom J; Weidinger G;
Thromb Haemost; 2003 Dec; 90(6):1100-5. PubMed ID: 14652643
[TBL] [Abstract][Full Text] [Related]
7. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].
Harenberg J; Piazolo L; Misselwitz F
Zentralbl Chir; 1998; 123(11):1284-7. PubMed ID: 9880848
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness analysis of enoxaparin for the prophylaxis of venous thromboembolism in major orthopedic surgery patients].
Brosa Riestra M; Rubio-Terrés C; Nadipelli V; Casado Collado A; Martínez Brotons F
Farm Hosp; 2003; 27(4):210-8. PubMed ID: 12966450
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin.
Colwell CW; Froimson MI; Mont MA; Ritter MA; Trousdale RT; Buehler KC; Spitzer A; Donaldson TK; Padgett DE
J Bone Joint Surg Am; 2010 Mar; 92(3):527-35. PubMed ID: 20194309
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of thromboembolism in hip traumatology: low molecular weight heparin versus dextran].
Hess P; Oertli D; Dürig M; Laffer U; Fridrich R; Jäger K; Harder F
Helv Chir Acta; 1992 May; 58(6):931-5. PubMed ID: 1379576
[TBL] [Abstract][Full Text] [Related]
12. Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery.
Glotzbecker MP; Bono CM; Harris MB; Brick G; Heary RF; Wood KB
Spine (Phila Pa 1976); 2008 Dec; 33(26):2915-21. PubMed ID: 19092624
[TBL] [Abstract][Full Text] [Related]
13. Dabigatran: new drug. Continue to use heparin, a better-known option.
Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
[TBL] [Abstract][Full Text] [Related]
14. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
15. Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry.
Bergqvist D; Arcelus JI; Felicissimo P;
Thromb Haemost; 2012 Feb; 107(2):280-7. PubMed ID: 22186771
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolic disease prophylaxis in patients undergoing orthopedic surgery of the lower extremity.
Colwell CW
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):2-3. PubMed ID: 12349891
[No Abstract] [Full Text] [Related]
17. Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium.
Annemans L; Minjoulat-Rey MC; De Knock M; Vranckx K; Czarka M; Gabriel S; Haentjens P
Acta Clin Belg; 2004; 59(6):346-57. PubMed ID: 15819379
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study on the use of a low-molecular-weight heparin for thromboembolism prophylaxis in large-volume liposuction and body contouring procedures.
Newall G; Ruiz-Razura A; Mentz HA; Patronella CK; Ibarra FR; Zarak A
Aesthetic Plast Surg; 2006; 30(1):86-95; discussion 96-7. PubMed ID: 16404651
[TBL] [Abstract][Full Text] [Related]
19. Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
Mrozik D; Jackiewicz A; Krzemiński M
Pol Orthop Traumatol; 2012 Oct; 77():111-4. PubMed ID: 23306297
[TBL] [Abstract][Full Text] [Related]
20. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
Dranitsaris G; Stumpo C; Smith R; Bartle W
Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
